There are 2867 resources available
385P - The prognostic value of circulating in blood tumor DNA after surgery in I-III stages colorectal cancer
Presenter: Elizeveta Polyanskaya
Session: Poster session 08
386P - Methylated circulating tumor DNA in plasma as a biomarker for treatment efficacy in metastatic colorectal cancer
Presenter: Louise Raunkilde
Session: Poster session 08
387P - Maintenance treatment with cetuximab versus observation in RAS wild-type metastatic colorectal cancer: Final results of the randomized phase II TIME-PRODIGE 28 UNICANCER study
Presenter: Valerie Boige
Session: Poster session 08
389P - Randomized phase II study of FOLFIRI plus ramucirumab versus FOLFOXIRI plus ramucirumab as first-line treatment for metastatic colorectal cancer: WJOG9216G (RECAST)
Presenter: Yosuke Kito
Session: Poster session 08
390P - Impact of age on treatment strategies in RAS/BRAF wild-type metastatic colorectal cancer (mCRC): A prespecified subgroup analysis of the GERCOR-PRODIGE STRATEGIC-1 phase III study
Presenter: Elisabeth Carola
Session: Poster session 08
392P - Updated data of biodistribution and activity of oncolytic virus TG6002 after intravenous administration in patients with advanced gastrointestinal carcinomas
Presenter: Victor Moreno Garcia
Session: Poster session 08
393P - Adherence to treatment recommendations from multidisciplinary tumor boards: Initial data from 562 colorectal cancer cases
Presenter: Jan Wagner
Session: Poster session 08
394P - Impact of gender on demographics, resectability, resections, systemic treatment, adverse events and outcomes in metastatic colorectal cancer (mCRC) patients (RAXO-study)
Presenter: Pia Osterlund
Session: Poster session 08